Tyler Rice

Participants with current moderate to severe chronic pain and opioid use were assessed for substance abuse problems.

Primary care diabetes prevention programs that promote physical activity become less effective when patients experience depressive symptoms.

Individuals taking extended-release injection naltrexone for opioid use disorder may be less likely to drop out of treatment after a single use of opioids compared with patients receiving placebo.

Prenatal opioid exposure may be associated with poorer cognitive and motor development in children from age 6 months to adolescence.

The US Food and Drug Administration has provided fast-track approval for the nonclinician use of Evzio, an easy-to-use autoinjectable device with a single dose of naloxone for the reversal of opioid overdose.

There may be a bidirectional association between migraine and some comorbid psychiatric disorders.

The prevalence of cluster headache may be higher in individuals with a substance use disorder than in the general population.

Opioid-related deaths, particularly those associated with synthetic opioids, increased in the eastern United States between 1999 and 2016, leading to lower life expectancies.

Current policy interventions aiming to curb opioid-related deaths are unlikely to be effective in the coming years.

Adolescents with atypical anorexia nervosa have higher bone mass density on average than adolescents with anorexia nervosa, but still experience significant deficits in fat mass index.

A panel of experts addressed several challenges associated with the implementation of the 2016 Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain.

Compared with patients who have onset type 2 diabetes at a usual age, adults with young-onset T2D are hospitalized significantly more often in their lifetimes.

Patients with chronic pain and a history of physical and sexual abuse were found to be more likely to concurrently use benzodiazepine and opioids.

The 3 main types of diabetes during pregnancy were associated with offspring ADHD risk in a hierarchical order.

The majority of adolescents taking prescription opioids for non-medical purposes were found to get these drugs from someone else.

The high-risk class was associated with risk factors such as complications after birth, elevated depressive symptoms during pregnancy, and previous mental illness.

Personality traits such as anxiety sensitivity, hopelessness, sensation seeking, and impulsivity may be predictors of use and misuse of prescription drugs in young adults.

There is sufficient evidence to suggest that physiology and culture underlie some of the variation in how depression and anxiety symptoms can manifest.

Researchers examined whether adjunctive gabapentin or memantine and standard treatment with a selective serotonin-reuptake inhibitor (SSRI) might lead to further improvements in patients with OCD.

Of the 14 families, 12 reported observing increased eye contact and greater social acuity in the children.

Researchers examined whether more severe appetitive symptoms predicted a positive response to light therapy.

The rate of suicide attempts in participants assigned to intervention plus treatment as usual was half of that in participants in the treatment as usual-alone group.

The use of intrinsic brain activity to differentiate acute suicidal acts from current suicidal thoughts is a promising step toward the development of an objective measure of imminent suicide risk.

Medicine-assisted treatment demonstrated strong benefits following the treatment period, including significantly lower odds for mental health hospitalization and fewer emergency department/crisis visits.

Non-research industry payments to physicians may be associated with increases in opioid prescribing rates.

Investigators assessed whether depressive symptoms during and after pregnancy were associated with neurodevelopmental disadvantages in children.

Participants in the prazosin group were more likely to experience dizziness on standing.